Claudio Cavazza's Net Worth
-$31.4 Thousand
Who is Claudio Cavazza?
Claudio Cavazza does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include QUESTCOR PHARMACEUTICALS INC, REGENERX BIOPHARMACEUTICALS INC, DOR BIOPHARMA INC, and SCICLONE PHARMACEUTICALS INC.
SEC CIK
Claudio Cavazza's CIK is 0001164803
Past Insider Trading and Trends
2005 was Claudio Cavazza's most active year for acquiring shares with 16 total transactions. Claudio Cavazza's most active month to acquire stocks was the month of February. 2005 saw Claudio Cavazza paying a total of $31,413.50 for 10,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
QUESTCOR PHARMACEUTICALS INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$4.68 |
—
| 7.25M |
Nov 20
| |||
Form 4
|
—
|
0
|
$1.50 |
—
| 9.5M |
Dec 20
| |||
Form 4
| +39.28% | 690K |
$1.45 | $1,000,500.00 | 2.45M |
Dec 13
| |||
Form 4
| -100.00% | -1.27M |
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
∞
| 100K |
$0.65 | $65,000.00 | 100K |
Apr 13
| |||
Form 4
| +22.27% | 100K |
$0.71 | $71,380.00 | 549.1K |
Apr 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
∞
| 759.49K |
$0.64 | $489,113.49 | 759.49K |
Jan 12
| |||
Form 4
| -0.06% | -10.00K |
$0.84 | -$8,409.00 | 16.43M |
Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
REGENERX BIOPHARMACEUTICALS INC (RGRXD) Snapshot price: $0.0005
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.02% | 2.22M |
$0.27 | $599,999.94 | 19.29M |
Jan 5
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +6.59% | 312.5K |
$0.40 | $125,000.00 | 5.05M |
Jun 2
| |||
Form 4/A
| +27.92% | 1.03M |
$1.45 | $1,499,998.90 | 4.74M |
Dec 10
| |||
Form 4
| +27.92% | 1.03M |
$1.45 | $1,499,998.90 | 4.74M |
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
| +207.37% | 2.5M |
$1.00 | $2,500,000.00 | 3.71M |
Feb 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
| +14.43% | 1.67M |
$1.80 | $2,999,998.80 | 13.22M |
Dec 21
| |||
Form 4
| +2.41% | 263.16K |
$1.50 | $394,737.00 | 11.18M |
Jul 14
| |||
Form 4
| +7.59% | 796.42K |
$2.81 | $2,237,954.25 | 11.29M |
Mar 6
| |||
Form 4
| +51.09% | 7.22M |
$2.64 | $9,699,996.39 | 21.35M |
Jun 11 - Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
DOR BIOPHARMA INC (SNGX) Snapshot price: $3.92
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +18.87% | 8.61M |
$0.21 | $1,764,758.90 | 54.23M |
Jun 18
| |||
Form 4
| +9.49% | 3.95M |
$0.25 | $999,999.96 | 45.62M |
Sep 24
| |||
Form 4
| +150.00% | 25M |
$0.18 | $4,500,000.00 | 41.67M |
Feb 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SCICLONE PHARMACEUTICALS INC No price found
InvestorClaudio Cavazza owns 394,615 units of Common Stock.acquired a total of 10,000 shares in SCICLONE PHARMACEUTICALS INC at a cost of $31,413.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.44% | 28.6K |
$2.05 | $58,604.26 | 6.58M |
Jan 30
| |||
Form 4
| +0.01% | 400 |
$2.05 | $820.00 | 6.55M |
Jan 28
| |||
Form 4
| +0.56% | 36.29K |
$2.05 | $74,224.71 | 6.55M |
Jan 24 - Jan 25
| |||
Form 4
| +0.45% | 29.13K |
$2.01 | $58,629.86 | 6.52M |
Jan 22 - Jan 23
| |||
Form 4/A
| +0.00% | 200 |
$2.00 | $400.00 | 6.42M |
Jan 14
| |||
Form 4
| +0.99% | 63.33K |
$2.01 | $127,553.06 | 6.49M |
Jan 15 - Jan 16
| |||
Form 4
| +0.44% | 28.4K |
$2.00 | $56,782.40 | 6.42M |
Jan 11 - Jan 14
| |||
Form 4
| +0.86% | 54.64K |
$2.04 | $111,574.88 | 6.39M |
Nov 13
| |||
Form 4
| +0.27% | 17.36K |
$2.05 | $35,548.48 | 6.34M |
Nov 7 - Nov 8
| |||
Form 4
| +0.64% | 40.26K |
$2.05 | $82,361.73 | 6.32M |
Nov 5
| |||
Form 4
| +0.87% | 54.12K |
$2.05 | $110,885.71 | 6.28M |
Nov 1 - Nov 2
| |||
Form 4
| +0.40% | 25K |
$2.05 | $51,250.00 | 6.23M |
Oct 19
| |||
Form 4
| +0.67% | 41.27K |
$2.05 | $84,598.95 | 6.2M |
Oct 17 - Oct 18
| |||
Form 4
| +1.15% | 70K |
$2.06 | $143,950.00 | 6.16M |
Oct 15 - Oct 16
| |||
Form 4
| +0.40% | 24.34K |
$1.95 | $47,388.97 | 6.09M |
Oct 1 - Oct 2
| |||
Form 4
| +0.08% | 5K |
$5.00 | $25,000.00 | 6.46M |
Dec 16
| |||
Form 4
| +27.61% | 1.4M |
$4.98 | $6,960,181.79 | 6.46M |
Jun 17
| |||
Form 4
| +1.47% | 73.52K |
$4.52 | $332,514.79 | 5.06M |
Jun 15 - Jun 16
| |||
Form 4
| +3.14% | 151.6K |
$4.19 | $634,950.00 | 4.99M |
Jun 10 - Jun 13
| |||
Form 4
| +14.49% | 612K |
$2.50 | $1,530,000.00 | 4.84M |
Jun 6 - Jun 7
| |||
Form 4
| +0.16% | 6.9K |
$2.58 | $17,787.51 | 4.22M |
Jun 1
| |||
Form 4
| +2.43% | 100K |
$2.43 | $243,180.00 | 4.22M |
May 26
| |||
Form 4
| +3.78% | 150K |
$2.38 | $357,170.00 | 4.12M |
May 24 - May 25
| |||
Form 4
| +0.86% | 33.8K |
$5.00 | $169,000.00 | 3.97M |
May 6
| |||
Form 4
| +0.01% | 481 |
$2.70 | $1,298.70 | 3.93M |
Apr 18
| |||
Form 4
| +0.76% | 29.5K |
$2.79 | $82,177.40 | 3.93M |
Apr 14 - Apr 15
| |||
Form 4
| +0.01% | 500 |
$5.00 | $2,500.00 | 3.9M |
Mar 30
| |||
Form 4
| +15.36% | 519.6K |
$5.00 | $2,598,000.00 | 3.9M |
Mar 18
| |||
Form 4
| +0.52% | 17.4K |
$5.00 | $87,000.00 | 3.38M |
Mar 3
| |||
Form 4
| +0.30% | 10K |
$3.14 | $31,413.50 | 3.36M |
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +1.30% | 43K |
$5.00 | $215,000.00 | 3.35M |
Nov 24 - Dec 17
| |||
No matching records found |